Skip to content

Shattuck Labs, Inc. STTK Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$106K
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$1.86M-20.0%
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB
$754K-56.5%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$2.06M-22.1%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$1.22M-35.9%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$3M-25.0%

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s accretion (amortization) of discounts and premiums, investments?
Shattuck Labs, Inc. (STTK) reported accretion (amortization) of discounts and premiums, investments of $48K in Q1 2026.
How has Shattuck Labs, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
Shattuck Labs, Inc.'s accretion (amortization) of discounts and premiums, investments increased by 2300.0% year-over-year, from $2K to $48K.
What is the long-term trend for Shattuck Labs, Inc.'s accretion (amortization) of discounts and premiums, investments?
Over 3 years (2021 to 2025), Shattuck Labs, Inc.'s accretion (amortization) of discounts and premiums, investments has grown at a -46.9% compound annual growth rate (CAGR), from -$3.04M to $454K.
What does accretion (amortization) of discounts and premiums, investments mean?
This represents the periodic adjustment to the carrying value of investment securities to reflect the amortization of premiums or the accretion of discounts over the life of the instrument. It reconciles the difference between the purchase price and the face value of debt securities held by the company. This adjustment is essential for accurately reflecting the effective interest income earned on the investment portfolio.